What does Ipca Labs do?
Ipca Laboratories Ltd is a large integrated pharmaceutical company that manufactures over 350 formulations and 80 active pharmaceutical ingredients. As of March 2025, it reported net sales of ₹22,467 Cr and a net profit of ₹678 Cr, with a market cap of ₹37,404 Cr.
Overview:Ipca Laboratories Ltd is a fully integrated pharmaceutical company that manufactures and markets over 350 formulations and 80 active pharmaceutical ingredients (APIs), operating within the Pharmaceuticals & Biotechnology industry and classified as a Large Cap company.History:
Ipca Laboratories was incorporated on 19 October 1949 under the name 'The Indian Pharmaceutical Combine Association Limited.' The latest quarterly results reported net sales and profit for the period ending March 2025.
Financial Snapshot:
Net Sales: 22,467 Cr (Quarterly Results - Mar 2025)
Net Profit: 678 Cr (Quarterly Results - Mar 2025)
Market Cap: INR 37,404 Cr (Large Cap)
Key Metrics:
P/E: 44.00
Industry P/E: 37
Dividend Yield: 0.27%
Debt-Equity: 0.04
Return on Equity: 12.13%
Price to Book: 5.35
Contact Details:
Address: 48 Kandivli Industrial Estate, Kandivli (West) Mumbai Maharashtra : 400067
Tel: 91-22-66474444
Email: ipca@ipca.co.in/investors@ipca.com
Website: http://www.ipca.com
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
